Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Clinical trial NCT02596893 · TERMINATED
Trial details
- NCT number
- NCT02596893
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-08
- Primary completion
- 2018-01-05
- Enrollment
- 701
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.